XML 107 R95.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidating Guarantor Financial Information (Schedule of Consolidating Statement of Cash Flows) (Details) - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by (used in) operating activities $ 745 $ 940
Investing Activities    
Capital expenditures on property, plant and equipment (180) (186)
Acquisitions, net of cash acquired (269) 0
Proceeds from sale of businesses and assets, net 1 8
Return of capital from subsidiary 0 0
Contributions to subsidiary 0 0
Intercompany loan receipts (disbursements) 0 0
Other, net (9) (14)
Net cash provided by (used in) investing activities (457) (192)
Financing Activities    
Net change in short-term borrowings with maturities of 3 months or less 224 (347)
Proceeds from short-term borrowings 150 39
Repayments of short-term borrowings (91) (76)
Proceeds from long-term debt 0 1,509
Repayments of long-term debt (65) (1,095)
Purchases of treasury stock, including related fees (500) (300)
Dividends to parent 0 0
Contributions from parent 0 0
Stock option exercises 1 3
Series A common stock dividends (178) (150)
Return of capital to parent 0 0
(Distributions to) contributions from noncontrolling interests (18) (15)
Other, net (19) (35)
Net cash provided by (used in) financing activities (496) (467)
Exchange rate effects on cash and cash equivalents 31 4
Net increase (decrease) in cash and cash equivalents (177) 285
Cash and cash equivalents as of beginning of period 638 967
Cash and cash equivalents as of end of period 461 1,252
Parent Guarantor [Member]    
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by (used in) operating activities 677 447
Investing Activities    
Capital expenditures on property, plant and equipment 0 0
Acquisitions, net of cash acquired 0 0
Proceeds from sale of businesses and assets, net 0 0
Return of capital from subsidiary 0 0
Contributions to subsidiary 0 0
Intercompany loan receipts (disbursements) 0 0
Other, net 0 0
Net cash provided by (used in) investing activities 0 0
Financing Activities    
Net change in short-term borrowings with maturities of 3 months or less 0 0
Proceeds from short-term borrowings 0 0
Repayments of short-term borrowings 0 0
Proceeds from long-term debt 0 0
Repayments of long-term debt 0 0
Purchases of treasury stock, including related fees (500) (300)
Dividends to parent 0 0
Contributions from parent 0 0
Stock option exercises 1 3
Series A common stock dividends (178) (150)
Return of capital to parent 0 0
(Distributions to) contributions from noncontrolling interests 0 0
Other, net 0 0
Net cash provided by (used in) financing activities (677) (447)
Exchange rate effects on cash and cash equivalents 0 0
Net increase (decrease) in cash and cash equivalents 0 0
Cash and cash equivalents as of beginning of period 0 0
Cash and cash equivalents as of end of period 0 0
Issuer [Member]    
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by (used in) operating activities 623 437
Investing Activities    
Capital expenditures on property, plant and equipment 0 0
Acquisitions, net of cash acquired (11) 0
Proceeds from sale of businesses and assets, net 0 0
Return of capital from subsidiary 0 145
Contributions to subsidiary 0 0
Intercompany loan receipts (disbursements) (174) (283)
Other, net 0 0
Net cash provided by (used in) investing activities (185) (138)
Financing Activities    
Net change in short-term borrowings with maturities of 3 months or less 245 (344)
Proceeds from short-term borrowings 0 0
Repayments of short-term borrowings 0 0
Proceeds from long-term debt 0 1,589
Repayments of long-term debt 0 (1,082)
Purchases of treasury stock, including related fees 0 0
Dividends to parent (678) (447)
Contributions from parent 0 0
Stock option exercises 0 0
Series A common stock dividends 0 0
Return of capital to parent 0 0
(Distributions to) contributions from noncontrolling interests 0 0
Other, net 0 (13)
Net cash provided by (used in) financing activities (433) (297)
Exchange rate effects on cash and cash equivalents 0 0
Net increase (decrease) in cash and cash equivalents 5 2
Cash and cash equivalents as of beginning of period 0 0
Cash and cash equivalents as of end of period 5 2
Subsidiary Guarantors [Member]    
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by (used in) operating activities 571 299
Investing Activities    
Capital expenditures on property, plant and equipment (122) (100)
Acquisitions, net of cash acquired (12) 0
Proceeds from sale of businesses and assets, net 0 1
Return of capital from subsidiary 18 750
Contributions to subsidiary 0 0
Intercompany loan receipts (disbursements) (25) (9)
Other, net (1) (9)
Net cash provided by (used in) investing activities (142) 633
Financing Activities    
Net change in short-term borrowings with maturities of 3 months or less 5 6
Proceeds from short-term borrowings 0 0
Repayments of short-term borrowings 0 0
Proceeds from long-term debt 174 746
Repayments of long-term debt (1) (635)
Purchases of treasury stock, including related fees 0 0
Dividends to parent (571) (398)
Contributions from parent 0 0
Stock option exercises 0 0
Series A common stock dividends 0 0
Return of capital to parent 0 0
(Distributions to) contributions from noncontrolling interests 0 0
Other, net (17) (20)
Net cash provided by (used in) financing activities (410) (301)
Exchange rate effects on cash and cash equivalents 0 0
Net increase (decrease) in cash and cash equivalents 19 631
Cash and cash equivalents as of beginning of period 51 21
Cash and cash equivalents as of end of period 70 652
Non-Guarantors [Member]    
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by (used in) operating activities 403 602
Investing Activities    
Capital expenditures on property, plant and equipment (58) (86)
Acquisitions, net of cash acquired (265) 0
Proceeds from sale of businesses and assets, net 20 7
Return of capital from subsidiary 0 0
Contributions to subsidiary 0 0
Intercompany loan receipts (disbursements) 0 90
Other, net (8) (5)
Net cash provided by (used in) investing activities (311) 6
Financing Activities    
Net change in short-term borrowings with maturities of 3 months or less (1) 0
Proceeds from short-term borrowings 150 39
Repayments of short-term borrowings (91) (76)
Proceeds from long-term debt 0 0
Repayments of long-term debt (64) (11)
Purchases of treasury stock, including related fees 0 0
Dividends to parent (280) 0
Contributions from parent 0 0
Stock option exercises 0 0
Series A common stock dividends 0 0
Return of capital to parent (18) (895)
(Distributions to) contributions from noncontrolling interests (18) (15)
Other, net (2) (2)
Net cash provided by (used in) financing activities (324) (960)
Exchange rate effects on cash and cash equivalents 31 4
Net increase (decrease) in cash and cash equivalents (201) (348)
Cash and cash equivalents as of beginning of period 587 946
Cash and cash equivalents as of end of period 386 598
Eliminations [Member]    
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by (used in) operating activities (1,529) (845)
Investing Activities    
Capital expenditures on property, plant and equipment 0 0
Acquisitions, net of cash acquired 19 0
Proceeds from sale of businesses and assets, net (19) 0
Return of capital from subsidiary (18) (895)
Contributions to subsidiary 0 0
Intercompany loan receipts (disbursements) 199 202
Other, net 0 0
Net cash provided by (used in) investing activities 181 (693)
Financing Activities    
Net change in short-term borrowings with maturities of 3 months or less (25) (9)
Proceeds from short-term borrowings 0 0
Repayments of short-term borrowings 0 0
Proceeds from long-term debt (174) (826)
Repayments of long-term debt 0 633
Purchases of treasury stock, including related fees 0 0
Dividends to parent 1,529 845
Contributions from parent 0 0
Stock option exercises 0 0
Series A common stock dividends 0 0
Return of capital to parent 18 895
(Distributions to) contributions from noncontrolling interests 0 0
Other, net 0 0
Net cash provided by (used in) financing activities 1,348 1,538
Exchange rate effects on cash and cash equivalents 0 0
Net increase (decrease) in cash and cash equivalents 0 0
Cash and cash equivalents as of beginning of period 0 0
Cash and cash equivalents as of end of period $ 0 $ 0